Facebook
Twitter
Telegram
Report an ErrorBurning Rock Biotech Limited Balance Sheet 2011-2024 | BNR
Annual Balance Sheet Burning Rock Biotech Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | -76 M | -7.69 M | - | - | - | - | - | - | - |
Long Term Debt |
- | - | 18.3 M | 87.6 M | - | - | - | - | - | - | - |
Long Term Debt Current |
- | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
61.1 M | 491 K | 47.6 M | 691 M | - | - | - | - | - | - | - |
Total Current Liabilities |
372 M | 242 M | 164 M | - | - | - | - | - | - | - | - |
Total Liabilities |
433 M | 242 M | 212 M | 976 M | - | - | - | - | - | - | - |
Deferred Revenue |
143 M | 74.4 M | 49.5 M | 58 M | - | - | - | - | - | - | - |
Retained Earnings |
-2.23 B | -1.42 B | -946 M | -612 M | - | - | - | - | - | - | - |
Total Assets |
2.28 B | 2.66 B | 848 M | 373 M | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | 1.9 B | 94.2 M | 95.3 M | - | - | - | - | - | - | - |
Book Value |
1.85 B | 2.42 B | 636 M | -603 M | - | - | - | - | - | - | - |
Total Shareholders Equity |
1.85 B | 2.42 B | -891 M | -603 M | - | - | - | - | - | - | - |
All numbers in CNY currency
Quarterly Balance Sheet Burning Rock Biotech Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | 49.3 M | - | - | - | - | - | - | - | 18.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 61.1 M | - | - | - | 491 K | - | - | - | 47.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | - | 433 M | - | - | - | 242 M | - | - | - | 212 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | 143 M | - | - | - | 74.4 M | - | - | - | 49.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | - | - | -2.23 B | - | - | - | -1.42 B | - | - | - | -946 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
- | - | - | - | 2.28 B | - | - | - | 2.66 B | - | - | - | 848 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | - | - | - | 1.43 B | - | - | - | 1.9 B | - | - | - | 94.2 M | - | - | - | 93.3 M | - | - | - | 54.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
- | - | - | - | 1.85 B | - | - | - | 2.42 B | - | - | - | 636 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | - | - | - | 1.85 B | - | - | - | 2.42 B | - | - | - | -891 M | - | - | - | -603 M | - | - | - | -372 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in CNY currency